Vyne Therapeutics (VYNE) Q4 2023 Earnings

29FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.82
-1.94
-1.06
-0.18

Details

Expected EPS
-0.5
Actual EPS
-0.18
Surprise EPS
0.32
Surprise Percent
+64%

Description

Vyne Therapeutics (VYNE) has reported earnings of -0.18 per share for Q4 2023.

0 Comments

Share your thoughts